|
PCNP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.697000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.872000E-01 |
| Normal-vs-Stage2 |
9.679800E-01 |
| Normal-vs-Stage3 |
7.338100E-02 |
| Normal-vs-Stage4 |
1.599940E-02 |
| Stage1-vs-Stage2 |
7.599000E-01 |
| Stage1-vs-Stage3 |
2.062400E-02 |
| Stage1-vs-Stage4 |
2.481000E-03 |
| Stage2-vs-Stage3 |
2.308000E-01 |
| Stage2-vs-Stage4 |
1.317020E-01 |
| Stage3-vs-Stage4 |
6.431400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.191000E-01 |
| Normal-vs-AfricanAmerican |
7.175500E-03 |
| Normal-vs-Asian |
7.201800E-01 |
| Caucasian-vs-AfricanAmerican |
1.312170E-02 |
| Caucasian-vs-Asian |
6.873000E-01 |
| AfricanAmerican-vs-Asian |
1.430950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.199030E-01 |
| Normal-vs-Female |
7.245600E-01 |
| Male-vs-Female |
5.794200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.984600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.808200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.124000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.443300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.697600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.891000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.747900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.634400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.069770E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.183500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.335600E-02 |
| Normal-vs-Grade 2 |
1.548810E-01 |
| Normal-vs-Grade 3 |
2.239800E-02 |
| Normal-vs-Grade 4 |
6.33270000000019E-05 |
| Grade 1-vs-Grade 2 |
3.298600E-01 |
| Grade 1-vs-Grade 3 |
4.459900E-03 |
| Grade 1-vs-Grade 4 |
4.012300E-04 |
| Grade 2-vs-Grade 3 |
7.78810000000574E-05 |
| Grade 2-vs-Grade 4 |
1.67079999946473E-07 |
| Grade 3-vs-Grade 4 |
8.221600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.795710E-02 |
| Normal-vs-ccB subtype |
1.558110E-02 |
| ccA subtype-vs-ccB subtype |
1.0241000000244E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.567000E-01 |
| Normal-vs-N1 |
2.222400E-02 |
| N0-vs-N1 |
1.606020E-01 |
|
|
